Norepinephrine and Dopamine Injection Into Lateral Brain Ventricle of the Rat and Growth Hormone-Releasing Activity in the Hypothalamus and Plasma
Eugenio E. Müller, Antonio Pecile, MATILDE FELICI, DANIELA COCCHP
Abstract
Eugenio E. Müller, Antonio Pecile, MATILDE FELICI, DANIELA COCCHP
Abstract
The effect of norepinephrine (NE) or dopamine (DA) on the growth hormonereleasing (GRF) activity in the hypothalamus and plasma of intact or hypophysectomized rats was studied by administering the catecholamines into the lateral ventricle of the brain. Growth hormone-releasing activity was evaluated by the depletion of pituitary growth hormone produced by intracarotid injection of hypothalamic extracts or plasma. NE and DA at doses known to be effective in depleting GH from the pituitary (0.5 μg) induced in intact and hypophysectomized rats disappearance of GRF activity from the hypothalamus and its appearance in plasma from hypophysectomized but not from intact rats. Unlike adrenergic compounds, serotonin (0.5 μg) was inactive. In intact rats NE given intraventricularly induced a depletion of pituitary GH activity at doses from 0.05 to 0.0025 μg. Dopamine at a dose of 0.005 μg was inactive. These results, while pointing to a hypothalamic site of action for the GH-releasing effect of catecholamines, tend to suggest that norepinephrine is the synaptic transmitter which releases GRF from its neurosecretory neurons. (Endocrinology86: 1376, 1970)
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of norepinephrine (NE) or dopamine (DA) on the growth hormonereleasing (GRF) activity in the hypothalamus and plasma of intact or hypophysectomized rats was studied by administering the catecholamines into the lateral ventricle of the brain. Growth hormone-releasing activity was evaluated by the depletion of pituitary growth hormone produced by intracarotid injection of hypothalamic extracts or plasma. NE and DA at doses known to be effective in depleting GH from the pituitary (0.5 μg) induced in intact and hypophysectomized rats disappearance of GRF activity from the hypothalamus and its appearance in plasma from hypophysectomized but not from intact rats. Unlike adrenergic compounds, serotonin (0.5 μg) was inactive. In intact rats NE given intraventricularly induced a depletion of pituitary GH activity at doses from 0.05 to 0.0025 μg. Dopamine at a dose of 0.005 μg was inactive. These results, while pointing to a hypothalamic site of action for the GH-releasing effect of catecholamines, tend to suggest that norepinephrine is the synaptic transmitter which releases GRF from its neurosecretory neurons. (Endocrinology86: 1376, 1970)
Key concepts: Internal medicine, Endocrinology, Hypothalamus, Dopamine, Norepinephrine, Chemistry, Serotonin, Ventricle